KHẢO SÁT KHẢ NĂNG TUÂN THỦ ĐIỀU TRỊ CỦA NGƯỜI BỆNH GÚT BẰNG BỘ CÂU HỎI CQR5

Abstract

Objective: To evaluate treatment adherence among patients with gout using the Compliance Questionnaire for Rheumatology-5 (CQR5) and to identify factors associated with adherence. Methods: A cross-sectional study was conducted on 150 patients diagnosed with gout according to the 2015 EULAR/ACR criteria at Hanoi Medical University Hospital and Bach Mai Hospital from September 2024 to June 2025. Treatment adherence was assessed using the CQR5 instrument. Results: The overall adherence rate assessed by CQR5 was 52.7%. Factors significantly associated with reduced adherence included age ≥60 years (OR=2.3; p=0.042), manual labor occupation (OR=4.8; p<0.001), low educational attainment (OR=3.0; p=0.003), presence of multiple comorbidities (OR=2.0; p=0.042), disease duration ≥5 years (OR=2.16; p=0.028), chronic gout (OR=2.90; p=0.010), use of ≥3 medications per day (OR=4.4; p=0.001), and ≥3 daily doses (OR=3.4; p<0.001). Conclusion: Treatment adherence among patients with gout was relatively low. Comprehensive patient management strategies are required, emphasizing enhanced disease awareness, tailored support for older patients and those with multiple comorbidities, and optimization of treatment regimens to reduce polypharmacy. Such measures may improve adherence and long-term disease control.